Literature DB >> 32336960

The Role of Tranexamic Acid (TXA) in Military Trauma: Current Practices and Implications for the Future.

Hugh W Finlayson.   

Abstract

Objectives: To review current literature on the use of Tranexamic acid in battlefield trauma to assess its effects on mortality and determine whether or not it should become more widely used in both civilian and military trauma.A subsection was to look at the feasibility of administering Tranexamic acid in a pre-hospital setting to minimise the time between injury and drug administration.
Methods: A search of the literature was performed on a variety of databases using the terms described in table 1. The papers were then reviewed and analysed regarding the effects of the drug in trauma. Patients: The papers selected reviewed 21,160 patients as detailed in Table 2. These patients were across both military and civilian trauma units. Outcomes: The main outcomes being examined were the effects on short term mortality at 24 and 48 hours and whether there was any increase in the thromboembolic risk associated with the administration of Tranexamic acid.
Results: The review of the literature showed that Tranexamic acid had a significant effect on improving mortality across the board (17.4% vs 23.9% mortality (p = 0.03)). This was most marked in the more severely injured who had received over 10 units of transfused blood (14.4% vs 28.4% mortality (p = 0.004)).In terms of side effects Tranexamic acid was shown to be safe in large doses, which is key for battlefield administration where there is a tendency to err on the side of overtreating. Interestingly, the risk of thromboembolic events was similar to those not receiving Tranexamic acid. Conclusions: Tranexamic acid is a very safe and effective means of improving survival when used in combination with current practices involving the use of blood products and surgical interventions. Tranexamic acid can safely be administered in the pre-hospital setting to minimise the delay between injury and treatment. The use of Tranexamic acid should be incorporated into trauma management across the board in the both military and civilian cases particularly in the most severe cases.

Entities:  

Year:  2018        PMID: 32336960      PMCID: PMC7183734     

Source DB:  PubMed          Journal:  Traumatology (Tallahass Fla)        ISSN: 1085-9373


  14 in total

1.  Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study.

Authors:  Jonathan J Morrison; Joseph J Dubose; Todd E Rasmussen; Mark J Midwinter
Journal:  Arch Surg       Date:  2011-10-17

Review 2.  Battlefield trauma care then and now: a decade of Tactical Combat Casualty Care.

Authors:  Frank K Butler; Lorne H Blackbourne
Journal:  J Trauma Acute Care Surg       Date:  2012-12       Impact factor: 3.313

Review 3.  Local and systemic hemostatics as an adjunct to control bleeding in trauma.

Authors:  Chrysanthos Georgiou; Kyriakos Neofytou; Demetrios Demetriades
Journal:  Am Surg       Date:  2013-02       Impact factor: 0.688

4.  Tranexamic acid in the prehospital setting: Israel Defense Forces' initial experience.

Authors:  Ari M Lipsky; Amir Abramovich; Roy Nadler; Uri Feinstein; Gadi Shaked; Yitshak Kreiss; Elon Glassberg
Journal:  Injury       Date:  2013-09-07       Impact factor: 2.586

Review 5.  Tranexamic acid for trauma patients: a critical review of the literature.

Authors:  Andrew P Cap; David G Baer; Jean A Orman; James Aden; Kathy Ryan; Lorne H Blackbourne
Journal:  J Trauma       Date:  2011-07

Review 6.  Review article: update in trauma anesthesiology: perioperative resuscitation management.

Authors:  Joshua M Tobin; Albert J Varon
Journal:  Anesth Analg       Date:  2012-07-04       Impact factor: 5.108

7.  Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.

Authors:  Haleema Shakur; Ian Roberts; Raúl Bautista; José Caballero; Tim Coats; Yashbir Dewan; Hesham El-Sayed; Tamar Gogichaishvili; Sanjay Gupta; Jorge Herrera; Beverley Hunt; Pius Iribhogbe; Mario Izurieta; Hussein Khamis; Edward Komolafe; María-Acelia Marrero; Jorge Mejía-Mantilla; Jaime Miranda; Carlos Morales; Oluwole Olaomi; Fatos Olldashi; Pablo Perel; Richard Peto; P V Ramana; R R Ravi; Surakrant Yutthakasemsunt
Journal:  Lancet       Date:  2010-06-14       Impact factor: 79.321

Review 8.  Tranexamic acid (TXA) use in trauma.

Authors:  Bryan Boling; Kathryn Moore
Journal:  J Emerg Nurs       Date:  2012-09       Impact factor: 1.836

9.  Death on the battlefield (2001-2011): implications for the future of combat casualty care.

Authors:  Brian J Eastridge; Robert L Mabry; Peter Seguin; Joyce Cantrell; Terrill Tops; Paul Uribe; Olga Mallett; Tamara Zubko; Lynne Oetjen-Gerdes; Todd E Rasmussen; Frank K Butler; Russ S Kotwal; Russell S Kotwal; John B Holcomb; Charles Wade; Howard Champion; Mimi Lawnick; Leon Moores; Lorne H Blackbourne
Journal:  J Trauma Acute Care Surg       Date:  2012-12       Impact factor: 3.313

10.  CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial.

Authors:  Yashbir Dewan; Edward O Komolafe; Jorge H Mejía-Mantilla; Pablo Perel; Ian Roberts; Haleema Shakur
Journal:  Trials       Date:  2012-06-21       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.